0000899243-22-008056.txt : 20220228 0000899243-22-008056.hdr.sgml : 20220228 20220228160048 ACCESSION NUMBER: 0000899243-22-008056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220224 FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sprague John M CENTRAL INDEX KEY: 0001730056 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 22689193 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-24 0 0001492674 T2 Biosystems, Inc. TTOO 0001730056 Sprague John M 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Financial Officer Common Stock 2022-02-24 4 M 0 145719 A 191204 D Common Stock 2022-02-24 4 F 0 55008 0.4488 D 136196 D Restricted Stock Units 2022-02-24 4 M 0 145719 0.00 D Common Stock 145719 291439 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. 55,008 shares of common stock were automatically withheld at vesting to cover required tax withholding. On February 24, 2021 the reporting person was granted 437,158 RSU's that vest in three equal installments commencing on February 24, 2022. /s/ Michael Gibbs, Attorney-in-fact 2022-02-28